2010 - TTS International Congress


Genomics and Biomarkers

86.8 - A Highly Specific Novel 3 Gene-set Can Non-invasively Predict Operational Renal Allograft Tolerance

Presenter: Li, Li, Stanford, United States
Authors: Li L., Heish S., Scandling J., Sigdel T., Sarwal M.


A HIGHLY SPECIFIC NOVEL 3 GENE-SET CAN NON-INVASIVELY PREDICT OPERATIONAL RENAL ALLOGRAFT TOLERANCE

GENOMICS AND BIOMARKERS

L. Li1, S. Heish1, J.D. Scandling2, T. Sigdel3, M. Sarwal3
1Pediatric, Stanford University, Stanford/CA/UNITED STATES OF AMERICA, 2Medicine, Stanford University, Palo Alto/CA/UNITED STATES OF AMERICA, 3, Stanford University, stanford/UNITED STATES OF AMERICA

Body: Aim: To improve on the sensitivity and specificity of a peripheral blood transcriptional biomarker genepanel for diagnosis and prediction of operational tolerance in a heterogeneous cohort of 63 adult kidney transplant recipients. Methods: 31 peripheral blood samples were analyzed by oligonucleotide Agilent arrays from 3 different phenotypes from different transplant centers: 16 operational tolerant (TOL) kidney transplant patients without medications for more than 1 year, 10 with chronic graft injury and on triple maintenance immunosuppression (CAN), and 5 healthy donors (HD). Samples were used as a training set to define a minimum gene-set for diagnosis of operational tolerance which were cross validated on an 20 independant samples, including 9 TOL, previously run on cDNA microarrays (PNAS, 2007). Q-PCR was run on 21 genes to build a model for prediction of tolerance by logistic regression and tested on an independent sample set containing 7 TOL patients. Bioinformatics analysis including GeneSpring, AILUN, SAM, PAM, logistic regression and IPA were used. Results: Twenty-one unique genes were identified (FDR<5%) by prediction analysis of microarrays (PAM) and statistical analysis of microarray (SAM) as a minimum gene for TOL. Genes overlapping across cDNA and Agilent platforms, among the 21 set, could back predict 9 TOL samples run on cDNA arrays with 100% sensitivity and specificity. These genes are enriched in immune cell trafficking and 13/21 genes are regulated by TNF, IL6 and IL4. Multinomial logistic regression modeling by Q-PCR for all samples identified 3 genes as a minimal gene set for TOL in the array data-set with 93% sensitivity and PPV, and 90% specificity and NPV. The 3-gene model predicted TOL with 100% sensitivity and NPV, 80% specificity, and 88% PPV, in a blinded independent data-set containing 7 TOL patients. 2 out of the final 3 genes are highly expressed in B cells. Conclusion: A highly regulated minimal gene-set in peripheral blood has been validated across multiple patients groups and transplant centers. This gene-set can be used as a non-invasive monitoring tool for screening patients with stable operational tolerance after kidney transplantation. Serial measurement of expression for this gene-set in peripheral blood opens the door for deliberate immunosuppression minimization after transplantation, and should be further tested for its utility in also monitoring patients on tolerance induction protocols in kidney transplantation.

Disclosure: All authors have declared no conflicts of interest.


You must be logged in to view recordings

Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.